Is this FTSE 100 stock owned by Terry Smith and Nick Train a screaming buy?

G A Chester looks at the valuation and prospects of a popular FTSE 100 ‘Warren Buffett-style’ stock.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

There’s almost universal love among my Motley Fool colleagues for FTSE 100 software giant Sage (LSE: SGE). The company, which released its annual results today, is also a favourite of luminary fund managers Terry Smith and Nick Train.

As such, my caution over the past year about the valuation and prospects of the business has put me out on something of a limb. Have today’s results, and share price fall of as much as 5%, persuaded me the valuation and prospects are now more attractive for investors?

Merited premium rating

To put today’s results (for its financial year ended 30 September) into context, let’s go back two years to the company’s near-term expectations, medium-term guidance, and long-term aims for the business.

For its financial year ending 30 September 2018, it said it expected organic revenue growth of around 8% and an organic operating margin of around 27.5%.

At a subsequent Capital Markets Day, it issued “mid-term guidance that over the next three years, organic revenue growth will reach 10% on a sustainable basis and organic operating margins will be at least 27%.”

It also said: “Over the long term, Sage has an aim of achieving organic operating margins of at least 30%.”

At the time, its shares were trading at around 750p. This valued it at 22.7 times trailing earnings per share (EPS) of 33.1p. Certainly a premium rating, but arguably well-merited on its projections for impressive, double-digit revenue growth and high profit margins.

Well short of expectations

Sage’s performance in fiscal 2018 fell well short of expectations. The chief executive walked the plank before the year was out, and was replaced by the finance director. The company reported organic revenue growth of just 6.8% for the year.

The new boss gave no concrete guidance on organic revenue growth for fiscal 2019, beyond telling us the rate may decrease in the short-term.” However, he said that due to “£60m of specifically targeted investment to accelerate the transition to SaaS … organic operating margin will be in the range of 23%-25%.”

Valuation

Today, Sage reported organic revenue growth of 5.6%, and an organic operating margin of 23.7%, having previously alerted the market in a Q3 update it would be at the lower end of the 23%-25% range. For fiscal 2020, management told us “organic operating margin is expected to be around 23%, as Sage continues to invest in the transition to SaaS.”

Two years ago, when the company was guiding on organic revenue growth reaching 10% within three years and organic operating margins of at least 27% (with a longer-term aim of at least 30%), the stock was trading at 750p and at 22.7 times earnings.

How’s the valuation looking today, with organic revenue growth running at 5.6% and margin guidance of 23% for fiscal 2020? The shares are dealing at 707p, which represents 24.9 times today’s reported underlying EPS of 28.4p.

As you can see, the stock’s earnings valuation is more elevated now than it was two years ago, when the market was pricing it for significantly stronger top-line growth and higher profit margins.

I believe the valuation is too high for the level of growth and margins it’s likely to offer going forward in an increasingly competitive market. At a sub-20 earnings multiple I might be interested, but at around 25 I’ll continue to avoid it.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

G A Chester has no position in any of the shares mentioned. The Motley Fool UK has recommended Sage Group. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Publish Test

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut…

Read more »

Investing Articles

JP P-Press Update Test

Read more »

Investing Articles

JP Test as Author

Test content.

Read more »

Investing Articles

KM Test Post 2

Read more »

Investing Articles

JP Test PP Status

Test content. Test headline

Read more »

Investing Articles

KM Test Post

This is my content.

Read more »

Investing Articles

JP Tag Test

Read more »

Investing Articles

Testing testing one two three

Sample paragraph here, testing, test duplicate

Read more »